Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Endocrinology

• Publication date

  2007-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/EN.2007-0270PMID 17395698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesenchymal Stem Cells and Osteoblast Differentiation

  2008cited by this paper
• Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo.

  2007cited by this paper
• Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.

  2007cited by this paper
• Dickkopf-1 is a master regulator of joint remodeling

  2007cited by this paper
• Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men.

  2007cited by this paper
• P-Ware: A precise and scalable component-based simulation tool for embedded multiprocessor industrial applications

  2007cited by this paper
• The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway.

  2006cited by this paper
• Bone Density Ligand, Sclerostin, Directly Interacts With LRP5 but Not LRP5G171V to Modulate Wnt Activity

  2006cited by this paper
• Wnt/beta-catenin signaling in development and disease.

  2006cited by this paper
• New Potential Targets for Treating Myeloma Bone Disease

  2006cited by this paper
• The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin.

  2006cited by this paper
• Generation and Characterization of dickkopf3 Mutant Mice

  2006cited by this paper
• Cellular and Molecular Mechanisms of Synovial Joint and Articular Cartilage Formation

  2006cited by this paper
• Orally Bioavailable GSK‐3α/β Dual Inhibitor Increases Markers of Cellular Differentiation In Vitro and Bone Mass In Vivo

  2006cited by this paper
• Multiple roles of mesenchymal beta-catenin during murine limb patterning.

  2006cited by this paper
• Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass

  2006cited by this paper
• Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.

  2006cited by this paper
• LRP5 Mutations Linked to High Bone Mass Diseases Cause Reduced LRP5 Binding and Inhibition by SOST*

  2006cited by this paper
• Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.

  2006cited by this paper
• Mechanical stimulation in vivo reduces osteocyte expression of sclerostin.

  2006cited by this paper
• Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases

  2006cited by this paper
• Multiple roles of mesenchymal β-catenin during murine limb patterning

  2006cited by this paper
• Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.

  2006cited by this paper
• Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.

  2005cited by this paper
• Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation

  2005cited by this paper
• Wnt-independent activation of beta-catenin mediated by a Dkk1-Fz5 fusion protein.

  2005cited by this paper
• Casein kinase 1 γ couples Wnt receptor activation to cytoplasmic signal transduction

  2005cited by this paper
• Wnt-independent activation of β-catenin mediated by a Dkk1-Fz5 fusion protein

  2005cited by this paper
• Essential Role of β-Catenin in Postnatal Bone Acquisition*

  2005influential reference
• A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation

  2005cited by this paper
• Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis.

  2005cited by this paper
• SOST is a target gene for PTH in bone.

  2005cited by this paper
• Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.

  2005cited by this paper
• Prostate cancer cells promote osteoblastic bone metastases through Wnts.

  2005cited by this paper
• Essential role of beta-catenin in postnatal bone acquisition.

  2005cited by this paper
• Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass

  2005cited by this paper
• Interaction between LRP5 and Frat1 Mediates the Activation of the Wnt Canonical Pathway*

  2005cited by this paper
• Design of cathepsin K inhibitors for osteoporosis.

  2005cited by this paper
• Dkk-1-derived Synthetic Peptides and Lithium Chloride for the Control and Recovery of Adult Stem Cells from Bone Marrow*

  2005cited by this paper
• Expression Profile of Osteoblast Lineage at Defined Stages of Differentiation*

  2005cited by this paper
• Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts.

  2005cited by this paper
• BMP signaling in skeletal development.

  2005cited by this paper
• Heterozygous Mutations in the LDL Receptor‐Related Protein 5 (LRP5) Gene Are Associated With Primary Osteoporosis in Children

  2005cited by this paper
• Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction.

  2005cited by this paper
• Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

  2005influential reference
• Association of Functionally Different RUNX2 P2 Promoter Alleles With BMD

  2005cited by this paper
• SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor*

  2005cited by this paper
• Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice.

  2005influential reference
• Reduced Relative Risk of Fractures Among Users of Lithium

  2005cited by this paper
• Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density

  2004cited by this paper
• The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice.

  2004cited by this paper
• Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton

  2004cited by this paper
• Bone Morphogenetic Proteins

  2004cited by this paper
• Contribution of the LRP5 Gene to Normal Variation in Peak BMD in Women

  2004cited by this paper
• BMP‐2 Controls Alkaline Phosphatase Expression and Osteoblast Mineralization by a Wnt Autocrine Loop

  2003cited by this paper
• Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.

  2003cited by this paper
• Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

  2003cited by this paper
• GSK-3: tricks of the trade for a multi-tasking kinase

  2003cited by this paper
• Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling.

  2003cited by this paper
• The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.

  2003cited by this paper
• Identification of genes regulated during osteoblastic differentiation by genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro.

  2003cited by this paper
• High Bone Mass in Mice Expressing a Mutant LRP5 Gene

  2003influential reference
• The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.

  2002cited by this paper
• Kremen proteins interact with Dickkopf1 to regulate anteroposterior CNS patterning

  2002cited by this paper
• A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population.

  2002influential reference
• High bone density due to a mutation in LDL-receptor-related protein 5.

  2002cited by this paper
• Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling.

  2002cited by this paper
• Second Cysteine-rich Domain of Dickkopf-2 Activates Canonical Wnt Signaling Pathway via LRP-6 Independently of Dishevelled*

  2002cited by this paper
• High bone density due to a mutation in LDL-receptor-related protein 5.

  2002cited by this paper
• Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

  2002influential reference
• A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.

  2002cited by this paper
• Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease

  2002influential reference
• Alleles of RUNX2/CBFA1 Gene Are Associated With Differences in Bone Mineral Density and Risk of Fracture

  2002cited by this paper
• Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling

  2002cited by this paper
• Regulation of Wnt/LRP Signaling by Distinct Domains of Dickkopf Proteins

  2002cited by this paper
• LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

  2001cited by this paper
• Minireview: the OPG/RANKL/RANK system.

  2001cited by this paper
• Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6.

  2001cited by this paper
• Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse.

  2001cited by this paper
• Cathepsin K, Osteoclastic Resorption, and Osteoporosis Therapy

  2001influential reference
• Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).

  2001cited by this paper
• Overexpression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 decreases bone density in adult mice and induces dwarfism.

  2001cited by this paper
• LDL-receptor-related protein 6 is a receptor for Dickkopf proteins

  2001cited by this paper
• Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development.

  2001cited by this paper
• Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

  2001cited by this paper
• Regulation of GSK-3: a cellular multiprocessor.

  2001cited by this paper
• Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow

  2001cited by this paper
• Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair

  2001cited by this paper
• arrow encodes an LDL-receptor-related protein essential for Wingless signalling

  2000cited by this paper
• Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

  1999cited by this paper
• Functional and structural diversity of the human Dickkopf gene family.

  1999cited by this paper
• Cleidocranial dysplasia: clinical and molecular genetics

  1999cited by this paper
• Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia.

  1997cited by this paper
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997influential reference
• Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

  1997cited by this paper
• Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.

  1997cited by this paper
• The FASEB Journal express article 10.1096/fj.05-4221fje. Published online August 25, 2005. ©2005 FASEB

  year unknowncited by this paper

• Three signalling pathways for iron overload in osteoporosis: a narrative review

  2025cites this paper
• Hindlimb Unloading Reversibly Attenuates Osteogenic Potential of Rat Skeletal Stem and Progenitor Cells ex vivo

  2025cites this paper
• Role of sclerostin in mastocytosis bone disease

  2025cites this paper
• Recent Advances in Osteoporosis Therapeutics.

  2025cites this paper
• Wnt/β-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy

  2025cites this paper
• Rhythms in Remodeling: Posttranslational Regulation of Bone by the Circadian Clock

  2025cites this paper
• Interoceptive regulation of bone homeostasis: the interplay between the nervous and skeletal systems in pathophysiology.

  2025cites this paper
• Roles of myokines in osteoporosis under physiological and diabetic conditions

  2025cites this paper
• Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition

  2025cites this paper
• Bifurcate Regulation of Hematopoietic Homeostasis and Bone Osteogenesis by VHL‐HIF2α‐Controlled Adipocyte Function

  2025cites this paper
• Computed tomography provides a “one-stop-shop” targeted analysis for coronary artery calcification and osteoporosis: a review

  2025cites this paper
• Decoding the inflammatory-osteogenic axis in ankylosing spondylitis: mechanisms, dysregulation, and emerging therapeutic interventions

  2025cites this paper
• Bone-formation-related markers in osteonecrosis of the jaws and their correlation with radiographic findings

  2025cites this paper
• Nucleic acid aptamers in orthopedic diseases: promising therapeutic agents for bone disorders

  2025cites this paper
• Indolent Mastocytosis and Bone Health: Molecular Mechanisms and Emerging Treatment Options

  2025cites this paper
• Wnt/β-catenin pathway as a potential target for Parkinson’s disease: a cohort study of romosozumab using routinely collected health data in Japan

  2024cites this paper
• Cnidii Fructus: A traditional Chinese medicine herb and source of antiosteoporotic drugs.

  2024cites this paper
• Current therapeutic approach of chronic kidney disease‐mineral and bone disorder

  2024cites this paper
• β-catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model

  2024cites this paper
• Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors

  2024cites this paper
• Anti-sclerostin antibody therapy prevents post-ischemic osteonecrosis bone collapse via interleukin-6 association.

  2024cites this paper
• Multifunctional scaffolds for bone repair following age-related biological decline: Promising prospects for smart biomaterial-driven technologies.

  2024cites this paper
• Discovery of the small molecular inhibitors against sclerostin loop3 as potential anti-osteoporosis agents by structural based virtual screening and molecular design.

  2024cites this paper
• Effect of anti-sclerostin antibody on orthodontic tooth movement in ovariectomized rats

  2024cites this paper
• Emerging role of liver-bone axis in osteoporosis

  2024cites this paper
• Bone Turnover Markers and Wnt Signaling Modulators in Early Complex Regional Pain Syndrome. A Pre-specified Observational Study

  2024cites this paper
• An in silico approach to elucidate the pathways leading to primary osteoporosis: age-related vs. postmenopausal

  2024cites this paper
• Molecular Signaling Pathways and MicroRNAs in Bone Remodeling: A Narrative Review

  2024cites this paper
• Recent advances in senescence-associated secretory phenotype and osteoporosis

  2024cites this paper
• Leptin attenuates the osteogenic induction potential of BMP9 by increasing β-catenin malonylation modification via Sirt5 down-regulation

  2024cites this paper
• Chronic kidney disease and menopausal health: An EMAS clinical guide.

  2024cites this paper
• From Genomics to Metabolomics: Molecular Insights into Osteoporosis for Enhanced Diagnostic and Therapeutic Approaches

  2024cites this paper
• Laser-Modified Ti Surface Improves Paracrine Osteogenesis by Modulating the Expression of DKK1 in Osteoblasts

  2023cites this paper
• Future treatment of vascular calcification in chronic kidney disease

  2023cites this paper
• Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis

  2023cites this paper
• Exploring the mechanism of traditional Chinese medicine in regulating gut-derived 5-HT for osteoporosis treatment

  2023cites this paper
• Sclerostin: clinical insights in muscle–bone crosstalk

  2023cites this paper
• PRICKLE1 gene methylation and abnormal transcription in Chinese patients with ankylosing spondylitis.

  2023cites this paper
• Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis

  2023cites this paper
• Inhibition of GSK-3β Enhances Osteoblast Differentiation of Human Mesenchymal Stem Cells through Wnt Signalling Overexpressing Runx2

  2023cites this paper
• Inactivation of Sufu in cementoblasts accelerates external tooth root resorption

  2023cites this paper
• TGFβ1+CCR5+ neutrophil subset increases in bone marrow and causes age-related osteoporosis in male mice

  2023cites this paper
• Collagen triple-helix repeat containing 1 (CTHRC1) protein in rheumatoid arthritis patients: Relation to disease clinical, radiographic and ultrasound scores

  2023cites this paper
• The development of magnesium-based biomaterials in bone tissue engineering: A review.

  2023cites this paper
• Bone mineral density among β–thalassemic children: age and sex comparative study

  2023cites this paper
• Effects of Multiwall Carbon Nanotubes on Premature Kidney Aging: Biochemical and Histological Analysis

  2023cites this paper
• Clinical and radiological characteristics of two patients with osteoporosis–pseudoglioma syndrome caused by a pathogenic homozygotic variant in the LRP5 gene

  2023cites this paper
• Bone Remodeling and Modeling: Cellular Targets for Antiresorptive and Anabolic Treatments, Including Approaches Through the Parathyroid Hormone (PTH)/PTH-Related Protein Pathway

  2023cites this paper
• Systematic single-variant and gene-based association testing of thousands of phenotypes in 426,370 UK Biobank exomes

  2022cites this paper
• Bone Health: Basic and Applied Bone Biology

  2022cites this paper
• Frequency-specific sensitivity of 3T3-L1 preadipocytes to low-intensity vibratory stimulus during adipogenesis

  2022cites this paper
• Moxibustion attenuates inflammation and alleviates axial spondyloarthritis in mice: Possible role of APOE in the inhibition of the Wnt pathway

  2022cites this paper
• Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis

  2022cites this paper
• One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study

  2022cites this paper
• Head and neck squamous cancer cells enhance the differentiation of human mesenchymal stem cells to adipogenic and osteogenic linages in vitro

  2022cites this paper
• Therapeutic approaches to activate the canonical Wnt pathway for bone regeneration

  2022cites this paper
• Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes

  2022cites this paper
• Bone Response to Weight Loss Following Bariatric Surgery

  2022cites this paper
• Foxf2 represses bone formation via Wnt2b/β-catenin signaling

  2022cites this paper
• Transgenerational bone toxicity in F3 medaka (Oryzias latipes) induced by ancestral benzo[a]pyrene exposure: Cellular and transcriptomic insights.

  2022cites this paper
• Mast4 determines the cell fate of MSCs for bone and cartilage development

  2022cites this paper
• Potential therapeutic response in a severe case of autosomal dominant osteopetrosis type I

  2022cites this paper
• Collagen triple helix repeat containing 1 (CTHRC1) protein: A promising biomarker for evaluation of rheumatoid arthritis patients

  2022cites this paper
• A comparative analysis of the osteogenic capacity of osteoblasts from newborn and two-week-old rats.

  2022cites this paper
• miR-148a-3p facilitates osteogenic differentiation of fibroblasts in ankylosing spondylitis by activating the Wnt pathway and targeting DKK1

  2022cites this paper
• Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats.

  2022cites this paper
• Low Bone Mineral Density in Hemophiliacs

  2022cites this paper
• New Frontiers in Osteoporosis Management: Optimizing Sequential and Combination Therapy

  2022cites this paper
• Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment

  2022cites this paper
• Investigation of the relationship between serum sclerostin and dickkopf-1 protein levels with bone turnover in children and adolescents with type-1 diabetes mellitus

  2022cites this paper
• METTL14 upregulates TCF1 through m6A mRNA methylation to stimulate osteogenic activity in osteoporosis

  2022cites this paper
• Effects of Triiodothyronine on Human Osteoblast-Like Cells: Novel Insights From a Global Transcriptome Analysis

  2022cites this paper
• The Impact of Type 2 Diabetes Mellitus on the Markers of Osteoporosis (Sclerostin and CTRP3) in Postmenopausal Women: A Comparative, Observational, Study

  2021cites this paper
• TAp63 regulates bone remodeling by modulating the expression of TNFRSF11B/Osteoprotegerin

  2021cites this paper
• Comparison of Sclerostin Levels in Gingival Crevicular Fluid before and after Nonsurgical Therapy in Smokers and Nonsmokers with Chronic Periodontitis

  2021cites this paper
• PTEN Reduces BMP9-Induced Osteogenic Differentiation Through Inhibiting Wnt10b in Mesenchymal Stem Cells

  2021cites this paper
• Methotrexate treatment suppresses osteoblastic differentiation by inducing Notch2 signaling and blockade of Notch2 rescues osteogenesis by preserving Wnt/β‐catenin signaling

  2021cites this paper
• Construction of adenovirus vector expressing duck sclerostin and its induction effect on myogenic proliferation and differentiation in vitro

  2021cites this paper
• Romosozumab: A Novel Agent in the Management of Osteoporosis

  2021cites this paper
• Bone remodeling biology

  2021cites this paper
• Obesity and Bone Loss at Menopause: The Role of Sclerostin

  2021cites this paper
• IgD promotes pannus formation by activating Wnt5A-Fzd5-CTHRC1-NF-κB signaling pathway in FLS of CIA rats and the regulation of IgD-Fc-Ig fusion protein.

  2021cites this paper
• Multiple Myeloma Cells Alter Adipogenesis, Increase Senescence-Related and Inflammatory Gene Transcript Expression, and Alter Metabolism in Preadipocytes

  2021cites this paper
• Pathophysiology of Vascular Calcification and Bone Loss: Linked Disorders of Ageing?

  2021cites this paper
• Comparative Evaluation of Sclerostin Levels in Gingival Crevicular Fluid in the Treatment of Chronic Periodontitis Patients Using Diode Laser as an Adjunct to Scaling and Root Planing: A Clinico-biochemical Study

  2021cites this paper
• Biologic and Pathologic Aspects of Osteocytes in the Setting of Medication-Related Osteonecrosis of the Jaw (MRONJ).

  2021cites this paper
• Role of the Myokine Irisin on Bone Homeostasis: Review of the Current Evidence

  2021cites this paper
• Serum biomarkers for bisphosphonate-related osteonecrosis of the jaw: a prospective clinical study

  2021cites this paper
• Bioactivity and Antibacterial Behaviors of Nanostructured Lithium-Doped Hydroxyapatite for Bone Scaffold Application

  2021cites this paper
• Sclerostin small-molecule inhibitors promote osteogenesis by activating canonical Wnt and BMP pathways

  2021cites this paper
• A biodegradable, mechanically tunable micro‐arc oxidation AZ91D‐based composite implant with calcium phosphate/chitosan coating promotes long‐term bone tissue regeneration

  2021cites this paper
• Sclerostin and Dickkopf-1 Characteristics According to Age and Physical Activity Levels in Premenopausal Women.

  2021cites this paper
• Systematic single-variant and gene-based association testing of 3,700 phenotypes in 281,850 UK Biobank exomes

  2021cites this paper
• Association of Serum Sclerostin Level, Coronary Artery Calcification, and Patient Outcomes in Maintenance Dialysis Patients

  2021cites this paper
• In silico investigations on curcuminoids from Curcuma longa as positive regulators of the Wnt/β-catenin signaling pathway in wound healing

  2021cites this paper
• Betel leaf extract and its major component hydroxychavicol promote osteogenesis and alleviate glucocorticoid-induced osteoporosis in rats.

  2021cites this paper
• Targeting DKK1 prevents development of alcohol-induced osteonecrosis of the femoral head in rats.

  2021cites this paper
• Disorders of Mineral Metabolism II. Abnormalities of Mineral Homeostasis in the Newborn, Infant, Child, and Adolescent

  2021cites this paper
• Hematopoietic Wnts Modulate Endochondral Ossification During Fracture Healing

  2021cites this paper
• Reduction of mechanical loading in tendons induces heterotopic ossification and activation of the β-catenin signaling pathway

  2021cites this paper